Skip to main content
ASTAL LABORATORIES LIMITED logo

ASTAL LABORATORIES LIMITED — Investor Relations & Filings

Ticker · 512600 ISIN · INE307N01014 LEI · 8945004HO2WCBQ0CJ976 BSE.NS Manufacturing
Open in API
Filings indexed 445 across all filing types
Latest filing 2024-06-22 Regulatory Filings
Country IN India
Listing BSE.NS 512600

About ASTAL LABORATORIES LIMITED

https://miel.co.in/

Astal Laboratories Limited is a pharmaceutical organization engaged in the development, manufacturing, and marketing of a diverse range of pharmaceutical formulations. The company's product portfolio encompasses various dosage forms, including tablets, capsules, liquid orals, and topical preparations. It operates across several therapeutic categories, such as anti-infectives, analgesics, and gastrointestinal treatments. Astal Laboratories prioritizes quality control and adheres to established manufacturing standards to ensure the safety and efficacy of its products. The company focuses on providing accessible healthcare solutions through a robust distribution network and a commitment to research-driven formulation development.

Recent filings

Filing Released Lang Actions
Astal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/06/2024 ,inter alia, to consider and approve 1. To discuss/ finalize ....
Regulatory Filings Classification · 95% confidence The document is an intimation letter to the stock exchange (BSE Limited) about a forthcoming Board Meeting scheduled for June 29, 2024. The letter outlines the agenda items to be discussed, including the proposal for issuing securities on a preferential basis, approval of the Notice of the 31st Annual General Meeting, approval of the Board Report for the financial year ended March 31, 2024, and other procedural matters related to the AGM. It also mentions the closure of the trading window for insiders as per SEBI regulations. The document is a notification of a Board Meeting and related corporate actions, not the actual Board Report or financial statements. It is a regulatory announcement pursuant to SEBI Listing Obligations and Disclosure Requirements (LODR) Regulation 29, which mandates disclosure of Board Meeting dates and agenda. The document is relatively short (3471 characters) and serves as an announcement rather than a full report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such regulatory announcements that do not constitute full reports or financial disclosures.
2024-06-22 English
Submission of Intimation of closure of trading window.
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to the stock exchange (BSE Limited) informing about the closure of the trading window for insiders due to an upcoming Board Meeting. The letter references SEBI regulations related to insider trading and mentions the Board Meeting date where a proposal for issuing securities will be discussed. The document is short (2016 characters) and serves as an announcement or intimation rather than a detailed report or financial statement. It does not contain financial data, audit information, or detailed management discussion. It is primarily a regulatory compliance notification about trading restrictions ahead of a capital raising event. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2024-06-22 English
Submission of newspaper publication of extract of audited financial results for the quarter and year ended 31st March 2024.
Regulatory Filings
2024-05-26 English
Submission of appointment of Additional non executive independent director pursuant to regulation 30 of SEBI (LODR) Regulations, 2015.
Regulatory Filings
2024-05-25 English
Submission of intimation of keep and maintain Books of Accounts at a at a place other than the registered office of the Company.
Regulatory Filings
2024-05-24 English
Submission of intimation of change in corporate office of the company pursuant to regulation 30 (LODR).
Regulatory Filings
2024-05-24 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.